HIMS: Regulatory Arbitrage and the Future of Personalized Medicine RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Best Way to Take BPC 157: Dosage & Administration The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Forward progress